Twinaqt (Dolutegravir/Lamivudine)

Twinaqt is a dual-drug HIV treatment with Dolutegravir and Lamivudine, offering effective viral suppression in a single daily tablet.

pack size Price Add to Cart
60 Tablets - USD $2.60 Per pill$78.00
View Cart
120 Tablets - USD $2.20 Per pill$132.00
View Cart
180 Tablets - USD $2.00 Per pill$180.00
View Cart

Twinaqt (Dolutegravir/Lamivudine)

Active IngredientDolutegravir/Lamivudine
Indication:HIV infection
Manufacturer:Emcure Pharmaceuticals Ltd.
Packaging30 Tablets in bottle
Strength350mg
Delivery Time6 To 15 days

Twinaqt is a two-drug, once-daily antiretroviral combination tablet that contains Dolutegravir and Lamivudine. It is used for the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg who have no known or suspected resistance to either drug.

  • Dolutegravir is an integrase strand transfer inhibitor (INSTI) that blocks the integration of viral DNA into human DNA, stopping HIV replication.

  • Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the reverse transcriptase enzyme, also preventing the virus from multiplying.

Twinaqt offers a simplified two-drug regimen that is effective, well-tolerated, and reduces long-term medication exposure while maintaining viral suppression.

pack size

60 Tablets – USD $2.60 Per pill, 120 Tablets – USD $2.20 Per pill, 180 Tablets – USD $2.00 Per pill

There are no reviews yet.

Be the first to review “Twinaqt (Dolutegravir/Lamivudine)”